15-74589834-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4BP6_Very_StrongBS2
The NM_006465.4(ARID3B):c.712C>A(p.Arg238Arg) variant causes a synonymous change. The variant allele was found at a frequency of 0.00609 in 1,610,322 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0042 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0063 ( 34 hom. )
Consequence
ARID3B
NM_006465.4 synonymous
NM_006465.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.80
Genes affected
ARID3B (HGNC:14350): (AT-rich interaction domain 3B) This gene encodes a member of the ARID (AT-rich interaction domain) family of DNA-binding proteins. The encoded protein is homologous with two proteins that bind to the retinoblastoma gene product, and also with the mouse Bright and Drosophila dead ringer proteins. A pseudogene on chromosome 1p31 exists for this gene. Members of the ARID family have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation and possibly in chromatin structure modification. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.09).
BP6
Variant 15-74589834-C-A is Benign according to our data. Variant chr15-74589834-C-A is described in ClinVar as [Benign]. Clinvar id is 777463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 644 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARID3B | NM_006465.4 | c.712C>A | p.Arg238Arg | synonymous_variant | 5/9 | ENST00000346246.10 | NP_006456.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARID3B | ENST00000346246.10 | c.712C>A | p.Arg238Arg | synonymous_variant | 5/9 | 1 | NM_006465.4 | ENSP00000343126.5 | ||
ARID3B | ENST00000622429.1 | c.712C>A | p.Arg238Arg | synonymous_variant | 5/9 | 1 | ENSP00000477878.1 | |||
ARID3B | ENST00000566147.1 | c.-12C>A | 5_prime_UTR_variant | 2/3 | 3 | ENSP00000455668.1 |
Frequencies
GnomAD3 genomes AF: 0.00423 AC: 644AN: 152194Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
644
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00423 AC: 1056AN: 249896Hom.: 1 AF XY: 0.00390 AC XY: 527AN XY: 135080
GnomAD3 exomes
AF:
AC:
1056
AN:
249896
Hom.:
AF XY:
AC XY:
527
AN XY:
135080
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00629 AC: 9170AN: 1458010Hom.: 34 Cov.: 30 AF XY: 0.00605 AC XY: 4388AN XY: 725116
GnomAD4 exome
AF:
AC:
9170
AN:
1458010
Hom.:
Cov.:
30
AF XY:
AC XY:
4388
AN XY:
725116
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00423 AC: 644AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.00422 AC XY: 314AN XY: 74486
GnomAD4 genome
AF:
AC:
644
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
314
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at